All In MedTech

PMA device

ProACT Adjustable Continence Therapy for Men

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

3

PMA pathway

Device trials

2

Naming "ProACT Adjustable Continence"

MAUDE reports

91

Brand "ProACT Adjustable Continence", since 2015

PubMed studies

0

Mentioning "ProACT Adjustable Continence"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing ProACT Adjustable Continence Therapy for Men

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 3 of 3 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "ProACT Adjustable Continence", any status and sponsor, newest update first.

Open in Trial Radar
  • UromedicaNot on our public-company list

    NCT03767595 · 145 participants (planned) · Start Feb 19, 2019 · Primary completion Dec 31, 2031

    Device: ProACT Adjustable Continence Therapy for Men · For: Stress Urinary Incontinence

    Sites: Los Angeles, California; Santa Barbara, California; Denver, Colorado · 14 sites in all

  • UromedicaNot on our public-company list

    NCT00277095 · 123 participants · Start Aug 2005 · Primary completion Feb 2009

    Device: ProACT (Adjustable Continence Therapy) · For: Urinary Incontinence

    Sites: Tucson, Arizona; Los Angeles, California; Pembroke Pines, Florida · 10 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "ProACT Adjustable Continence", and for the whole product code for context.

This brand

91 reports: 4 malfunction, 86 injury, 0 death

Whole product code EZY

16,309 reports: 465 malfunction, 15,829 injury, 8 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "ProACT Adjustable Continence"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code EZY.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.